Strategies to Preserve Beta-Cell Function in Newly Diagnosed Type 1-Diabetes
Received Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Abstract
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing beta cells in the pancreas. This leads to absolute insulin deficiency, necessitating lifelong insulin therapy. Recent research emphasizes the importance of preserving residual beta-cell function in newly diagnosed T1D patients, as it can improve glycemic control and reduce complications. This article explores various strategies to preserve beta-cell function, including immunotherapy, lifestyle modifications, and novel pharmacological interventions.
Keywords: Type 1 diabetes; Beta-cell function; immunotherapy; GLP-1 agonists; SGLT-2 inhibitors; Lifestyle modifications; Continuous glucose monitoring; Diabetes management
Citation: Thompson L (2024) Strategies to Preserve Beta-Cell Function in Newly Diagnosed Type 1-Diabetes. J Diabetes Clin Prac 7: 267 Doi: 10.4172/jdce.1000267
Copyright: © 2024 Thompson L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 108
- [From(publication date): 0-0 - Feb 22, 2025]
- Breakdown by view type
- HTML page views: 77
- PDF downloads: 31
